Back to Results

Impact of Fever Prevention in Brain Injured Patients (INTREPID)

Study category: Other

Is this Study for You?

Let's Get Started!

Description

Patients randomized to the fever prevention group will have ArcticGel Pads placed on their body. These will be connected to the Arctic Sun System. The system will be programmed to keep the patient's body temperature at 98.6. Treatment will last for 14 days or until ready to be discharged from the ICU. Standard of care patients will receive standard medical care as prescribed by the medical team.

Details
Age

Adult

Eligibility

Adult, primary diagnosis of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage

Phase

Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.

Type of Study

Treatment

Location

University of Colorado Hospital

Principal Investigator
Luis Cava Prado,  MD

Luis Cava Prado, MD

Study ID

Protocol Number: 18-0548

More information available at ClinicalTrials.gov: NCT02996266

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers